# NIH Reporter #1P01CA314921-01

Metabolic Imaging of Anaplastic Thyroid Cancer to Assess Treatment Response

**Recipient:** UNIVERSITY OF TX MD ANDERSON CAN CTR

**Award Amount:** $490,611.00
**Ceiling:** $490,611.00

**Awarded:** September 17, 2026

**Identifier:** 1P01CA314921-01

The award supports research on metabolic imaging to monitor treatment response in aggressive anaplastic thyroid cancer, aiming to improve early detection of therapy effectiveness and resistance.

### Description

This project aims to develop advanced imaging techniques to study metabolic changes in tumor cells induced by targeted therapies and T-cell immunotherapy for anaplastic thyroid cancer (ATC). The goal is to improve diagnostic and therapeutic strategies by refining early indicators of treatment response or progression, ultimately enhancing patient outcomes.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11420949)